India's Most Valuable Companies 2024 edition · Source: Hurun India
Rank#336- Valuation
- ₹16,860 Cr
2022 #341 2021 #394
Revenue · FY 2025
₹5,053.33 Cr
▲ 87% YoY
Net profit · FY 2025
₹755.96 Cr
Net margin 15%
EBITDA · FY 2025
₹1,353.76 Cr
EBITDA margin 26.8%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.95 Cr
Issued & subscribed
Open charges
₹2,580.52 Cr
Satisfied ₹3,316.04 Cr
Company age
73 yrs
Est. 1953
Employees · EPFO
5,348
Provident fund records
About Biological E. Limited
Data last updated:
Biological E. Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 December 1953 and has been in existence for over 73 years.
Its director Mahima Datla and family are #143 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U01120TG1953PLC001095. Its GSTIN is 36AAACB7873P1Z0 (Telangana). The company holds 29 GST registrations, of which 24 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.95 Cr. It was formerly known as Biological Products Private Limited and Biological Products Limited. It is led by directors including Mahima Datla (Managing Director) and Rudaraju Anand Kumar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 23 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 18/1 And 3 Azamabad Hyderabad, Telangana, India – 500020.
As per the financials filed for FY 2025, the company reported a revenue of ₹5,053.33 Cr, a growth of 87% compared to the previous year. For the same year it recorded a net profit of ₹755.96 Cr (net margin 15%) and EBITDA of ₹1,353.76 Cr (EBITDA margin 26.8%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years.
The company has about 5,348 employees on its provident fund (EPFO) records. Its group structure includes 4 subsidiaries.
The company is associated with 2 brands: Akorn India and Biological E. As per MCA filings, the company has open charges of ₹2,580.52 Cr and satisfied charges of ₹3,316.04 Cr on record. Court records list 342 cases involving the company, including 219 filed by the company and 123 filed against it; 102 cases are pending. The company has 5 deals on record (3 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹2.79 Cr; the latest was in August 2024. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations) are compared by revenue, 1 larger and 4 smaller; the largest is Eris Lifesciences Limited with revenue of ₹2,912 Cr. The company has 45 MSME Form 1 returns on record between 2016 and 2024, listing 1,115 overdue payments to 383 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biologicale.com.
Company details
CIN U01120TG1953PLC001095
Registration Number 001095
Incorporation Date 10 December 1953
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 October 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Name history
Biological E has undergone 5 name changes throughout its history. The current legal name is Biological E. Limited.
| Company Name | Status |
|---|---|
| Biological E. Limited | Current |
| Biological Products Private Limited | Previous |
| Biological Products Limited | Previous |
| Evans Medical Supplies (India) Private Limited | Previous |
| Evans Medical Supplies (India) Limited | Previous |
| Biological Evans Limited | Previous |
CIN history
Biological E has one previous CIN (Corporate Identification Number): U01120AP1953PLC001095. The current CIN is U01120TG1953PLC001095, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U01120TG1953PLC001095 | Current |
| U01120AP1953PLC001095 | Previous |
Key People
Mahima Datla Managing Director Rudaraju Anand Kumar Whole-Time Director Narender Dev Mantena Whole-Time Director Recognitions & Rankings of Biological E
India's Richest People 2026 edition · 1 director · Source: Hurun India
- #143 Mahima Datla & family ₹25,200 Cr
Contact details
Biological E. Limited's registered office is in Hyderabad, Telangana. Its website is biologicale.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address18/1 And 3 Azamabad Hyderabad, Telangana, India – 500020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Biological E. Limited, buy the company report.
Comprehensive company report
Biological E. Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Biological E operates two associated brands: Akorn India and Biological E. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Sterile pharmaceuticals are developed, manufactured, and marketed by Akorn India. | akornindia.com | |
| Vaccines and therapeutics for multiple diseases are developed and marketed. | biologicale.com |
Business activity
The main business activity of Biological E is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Biological E. Limited, buy the company report.
Financials of Biological E. Limited
FY 2025 filings availableBiological E. Limited reported revenue of ₹5,053.33 Cr (up 87% YoY) for FY 2025.
Revenue · FY 2025
₹5,053.33 Cr ▲ 87%
Net profit · FY 2025
₹755.96 Cr margin 15%
EBITDA · FY 2025
₹1,353.76 Cr margin 26.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 87%
3 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 102%
3 years · compounded
▲ 31%
Revenue has grown at a compounded annual rate (CAGR) of 24% over three years, including 87% growth in the latest year. EBITDA rose 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹5,053.33 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1,353.76 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹755.96 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.8% | ||||
| Net Profit Margin | 15% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biological E. Limited, buy the company report.
Board of directors of Biological E. Limited
Biological E has 9 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narsing Rao Singayapally Also directs: Kaveri Seed Company Ltd., HBL Engineering Limited, SVLN Farm Fields Private Limited and 2 more | Additional Director | 07 Oct 2024 | 2 Years 1 Months | Current |
| Peter Baron Piot Also directs: Biocon Limited, Biocon Biologics Limited | Additional Director | 27 Nov 2024 | 1 Years 11 Months | Current |
| Rudaraju Anand Kumar Also directs: Technopharma Pvt Ltd, Biotech Medicals Private Limited, Biotech Pharma Pvt Ltd. and 5 more | Whole-Time Director | 16 Oct 2017 | 9 Years 0 Months | Current |
| Ippagunta Yasodhara Rama Krishna Rao | Director | 23 May 2017 | 9 Years 5 Months | Current |
| Mahima Datla | Managing Director | 10 Apr 2013 | 13 Years 7 Months | Current |
| Narender Dev Mantena Also directs: Vasishta Infotech LLP, Be Helfie (India) Private Limited, Be Biosol Private Limited and 1 more | Whole-Time Director | 07 Oct 2024 | 2 Years 1 Months | Current |
Showing 6 of 9 current directors. View all directors
Peer comparison
Biological E. Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biological E. Limitedthis company | ₹5,053.33 Cr (FY 2025) | ₹755.96 Cr | 15% | 87.0% | 5,348 | Hyderabad, Telangana, India |
| Eris Lifesciences Limited | ₹2,912 Cr (FY 2025) | 43.0% | Ahmedabad, Gujarat, India | |||
| Pfizer Limited | ₹2,453.6 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Marksans Pharma Limited | ₹2,227.83 Cr (FY 2024) | 17.0% | Mumbai, Maharashtra, India | |||
| FDC Limited | ₹2,198.78 Cr (FY 2025) | 8.0% | Mumbai, Maharashtra, India | |||
| Unichem Laboratories Limited | ₹2,146.29 Cr (FY 2025) | 18.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Biological E. Limited, buy the company report.
Auditor
Biological E. Limited is audited by BRAHMAYYA & CO for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BRAHMAYYA & CO | FY 2025 | 000513S |
Shareholding
The shareholding of Biological E. Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Biological E. Limited, buy the company report.
Charges & borrowings
Open charges
₹2,580.52 Cr
Satisfied charges
₹3,316.04 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Dec 2024 | 101027284 | Citi Bank N.A. | ₹250 Cr | Open | |
| 11 Dec 2024 | 101027287 | Citi Bank N.A. | ₹167.8 Cr | Open | |
| 01 Dec 2023 | 100862975 | Axis Bank Limited | ₹2.14 Cr | Open | |
| 17 Nov 2022 | 100650578 | Others | ₹300 Cr | Open | |
| 31 May 2022 | 100586488 | Hdfc Bank Limited | ₹350 Cr | Open |
To see the full charge records of Biological E. Limited, buy the company report.
Total charge records: 84 View all charges
Deals & funding
Biological E. Limited has 5 deals on record (3 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹2.79 Cr; the latest was in August 2024.
Total deals
5
Secondary share transfers
3
Funding round
1
Acquisition
1
Disclosed funding
₹2.79 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Mahima Trust, Poornima & Indu Trust |
| May 2013 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Vijay Kumar Datla HUF |
| Apr 2013 | Acquisition | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
| Nov 2007 | Funding round | ₹2.79 Cr | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Biological E. Limited has 342 court cases on record: 219 filed by Biological E, 123 filed against it. 102 cases are pending and 240 are disposed.
Total cases
342
Filed by the company
219
Filed against the company
123
Pending
102
Disposed
240
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 173 | 32 | 58 |
| High courts | 147 | 73 | 43 |
| Supreme Court | 20 | 18 | 1 |
| NCLT | 2 | 0 | 0 |
Cases on record (5 of 342)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (4805-Others : Matters not falling under any other category.) | Filed against the company by Union of India and 3 others | Pending |
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Ready Bio Pharmaceuticals Pvt Ltd, Rep. by Sri Sanjeev Kumar | Pending |
| High Court, TELANGANA | Revision petition | Filed against the company by M/S. Hill County Properties Limited and 1 other | Pending |
| High Court, MAHARASHTRA | Court case (COMMP) | Filed against the company by Cipla Limited | Pending |
| High Court, GUJARAT | Special civil application | Filed by the company against Gujarat Medical Services Corporation Ltd (Gmscl) and 3 others | Disposed |
To see the full case history of Biological E. Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Biological E. Limited was last rated by Icra on 27 May 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 27 May 2021 |
To see the full credit ratings and regulatory alerts of Biological E. Limited, buy the company report.
MSME payment delays
Biological E. Limited has 45 MSME Form 1 returns on record between 2016 and 2024, listing 1,115 overdue payments to 383 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 383)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Nanz Med Science Pharma Private Limited | |||
| 3D Foamcut Private Limited | |||
| Elite Precision Technologies Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Biological E. Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Biological E has 4 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
4
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Be Pharmaceuticals Private Limited | U24100TG2011PTC148362 | |
| Biotech Medicals Private Limited | U24230TG1999PTC032680 | |
| B.E. Investment and Finance Pvt Ltd | U65993TG1987PTC008036 | |
| Vaxenic India Private Limited | U74900TG2015PTC097587 |
To see the full group structure of Biological E. Limited, buy the company report.
Employees & EPFO
Biological E. Limited has a workforce of 5,348 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Employee count
5,348
Active EPFO establishments
2
Employee growth
-14.7%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 5,348 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Biological E. Limited, buy the company report.
GST
Biological E has 29 GST registrations: 24 active and 5 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
29
Active
24
Cancelled / inactive
5
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACB7873P1Z0 | Telangana | Active | 01 Jul 2017 |
| 36AAACB7873P2ZZ | Telangana | Active | 01 Jul 2017 |
| 36AAACB7873P3ZY | Telangana | Active | 23 Jan 2025 |
| 02AAACB7873P1ZB | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Biological E. Limited, buy the company report.
Recent activity
Biological E. Limited has 21 board changes on record since 2009: 10 appointments and 11 cessations. The latest: Peter Baron Piot was appointed as Additional Director on 27 Nov 2024.
AGM
Biological E. Limited last Annual general meeting of members was held on 23 Oct 2025 as per latest MCA records.
Filing
Biological E. Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Citi Bank N.A. amounted to Rs. 250.00 Cr with Charge ID 101027284 was registered on 11 Dec 2024.
Charges
A charge with Citi Bank N.A. amounted to Rs. 167.80 Cr with Charge ID 101027287 was registered on 11 Dec 2024.
Appointed
Peter Baron Piot was appointed as Additional Director.
Ceased
Venkata Subbaraju Penmetsa ceased to be Additional Director.
Charges
A charge registered on 28 Dec 2021 via Charge ID 100521446 with Sbicap Trustee Company Limited was fully satisfied on 23 Oct 2024.
Charges
A charge registered on 14 Sep 2018 via Charge ID 100206996 with Sbicap Trustee Company Limited was fully satisfied on 23 Oct 2024.
Appointed
Narender Dev Mantena was appointed as Whole-Time Director.
Ceased
Narender Dev Mantena ceased to be Additional Director.
Appointed
Narsing Rao Singayapally was appointed as Additional Director.
Appointed
Venkata Subbaraju Penmetsa was appointed as Additional Director.
199 earlier events are in the company report.
News
Frequently asked questions
Biological E is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 December 1953 (73+ years old) and is registered under CIN U01120TG1953PLC001095.
Biological E has 9 current directors:
- Mahima Datla - Managing Director
- Rudaraju Anand Kumar - Whole-Time Director
- Narender Dev Mantena - Whole-Time Director
- Indira Smriti Rajupusapati - Whole-Time Director
- Mantena Purnima - Whole-Time Director
- Narsing Rao Singayapally - Additional Director
- Peter Baron Piot - Additional Director
- Ippagunta Yasodhara Rama Krishna Rao - Director
- Venkata Subbaraju Penmetsa - Additional Director
The latest financial statements of Biological E on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 October 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Biological E is 36AAACB7873P1Z0, registered in Telangana. The company has 29 GST registrations in all, of which 24 are active and 5 are cancelled or inactive. Other active GSTINs include 36AAACB7873P2ZZ (Telangana), 36AAACB7873P3ZY (Telangana), 02AAACB7873P1ZB (Himachal Pradesh).
The CIN (Corporate Identification Number) of Biological E is U01120TG1953PLC001095. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biological E has 342 court cases on record: 219 filed by the company and 123 filed against it. 102 are pending. Most are in the district courts.
Biological E was incorporated on 10 December 1953, making it 73+ years old. It is registered with the Registrar of Companies, Hyderabad.
Biological E has 5 deals on record (3 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹2.79 Cr; the latest was in August 2024.
The peers of Biological E by revenue are Eris Lifesciences Limited, Pfizer Limited, Marksans Pharma Limited, FDC Limited, Unichem Laboratories Limited, all in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Peter Baron Piot was appointed as Additional Director on 27 Nov 2024. Venkata Subbaraju Penmetsa ceased to be Additional Director on 26 Nov 2024. Narender Dev Mantena was appointed as Whole-Time Director on 07 Oct 2024. Biological E has 21 board changes on record in total.
Biological E has 45 MSME Form 1 returns on record between 2016 and 2024, listing 1,115 overdue payments to 383 micro and small suppliers. The latest return was filed on 21 Jun 2024.
Biological E can be reached through the website biologicale.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages